Advancedmolecular
Transcription Factors in Detail
Overview
Transcription factors (TFs) are proteins that bind regulatory DNA and control transcription: ~1,600 in humans (~8% of genes). They carry DNA-binding domains (zinc finger, helix-turn-helix, leucine zipper, bHLH) and activation/repression domains, work combinatorially at enhancers, and include general factors (TFIIA-H) plus sequence-specific regulators. Master TFs (Oct4/Sox2/Nanog, MyoD) define cell identity.
Learning objectives
- Name the major DNA-binding domain families
- Explain activation domains and coactivators
- Describe combinatorial control
- Give master-regulator examples
DNA-binding domains
Zinc fingers (C2H2): modular, one finger per 3 bp, the basis of engineered ZFNs. Helix-turn-helix: homeodomains patterning animal bodies (Hox genes). Leucine zipper and bHLH: dimerization + DNA binding (Myc, Fos/Jun/AP-1). Each family reads DNA shape and sequence differently.
A small repertoire of folds reads the entire regulatory genome combinatorially.
Activation and repression
Activation domains recruit Mediator, p300/CBP histone acetyltransferases, and remodelers to fire transcription. Repressors recruit HDACs and corepressors (or compete for binding). Nuclear receptors (estrogen, glucocorticoid) are ligand-gated TFs: hormone binding flips them from repressor to activator.
Steroid hormones work by converting their receptors from repressors to activators: endocrinology meets transcription.
Combinatorial control
No single TF defines a cell type; combinations do. The IFN-beta enhanceosome assembles 8+ factors on 55 bp for virus-triggered activation. This AND/OR logic gives specificity: each gene integrates multiple signals, each TF regulates hundreds of genes.
Knocking out a TF affects its whole regulon; phenotypes reflect network position, not single targets.
Master regulators
MyoD converts fibroblasts to muscle; Oct4/Sox2/Nanog maintain pluripotency (and reprogram iPSCs with Klf4/c-Myc); Hox genes pattern body axes. Mutations cause developmental syndromes (e.g., PAX6 in aniridia, FOXP2 in speech disorder).
Ectopic expression of a few TFs can convert cell fate: the basis of iPSC technology.
Key points
- ~1,600 human TFs with zinc finger, HTH, leucine zipper, bHLH domains
- Activation domains recruit coactivators/chromatin modifiers; repressors recruit HDACs
- Combinatorial binding at enhancers gives specific control
- Master TFs (MyoD, OSN, Hox) define and reprogram cell identity
Common misconceptions
✓ Truth: TFs are shared combinatorially: ~1,600 TFs regulate ~20,000 genes through combinations.
✓ Truth: Many repress (directly or by competition), and some switch with ligands or modifications.
Practice questions
Q1. Which is a DNA-binding domain family?
- Kinase domain
- Zinc finger
- SH2
- Transmembrane
C2H2 zinc fingers are the largest TF domain family in humans.
Q2. Nuclear receptors are transcription factors that
- Bind RNA
- Are gated by hormone ligands
- Make ATP
- Cut DNA
Hormone binding switches them between repressor and activator states.
Q3. Combinatorial control means
- One TF per gene
- Gene-specific TF combinations determine expression
- TFs work alone
- No regulation
Specificity emerges from combinations, not dedicated factors.
Click a question to reveal the answer and explanation.
Frequently asked questions
How do zinc-finger nucleases work?
Engineered zinc-finger arrays target a chosen sequence, fused to FokI nuclease to cut: pre-CRISPR genome editing.
What is the enhanceosome?
A precisely arranged multi-TF complex (e.g., IFN-beta) where cooperative assembly creates switch-like activation.
Why do Hox mutations transform body segments?
Hox genes give positional identity; misexpression respecifies segment fate (Antennapedia: legs for antennae).